Li et al. [123] showed that in cervical cancer, HMGB3 specifically binds to the promoter region of human telomerase reverse transcriptase (hTERT) and induces hTERT expression, leading to radioresistance in tumor cells. This evidence concerns the gene HMGB3 and cervical cancer.